Showing results (51-60 of 76) with videos related to
Sort By:
Pageof 8
Blood Cancer Journal|June 14, 2014
The novel immunotoxin HM1.24-ETA' induces apoptosis in multiple myeloma cellsM Staudinger, P Glorius, R Burger, et al.Blood|August 1, 1993
Involvement of the high-affinity receptor for IgG (Fc gamma RI; CD64) in enhanced tumor cell cytotoxicity of neutrophils during granulocyte colony-stimulating factor therapyT Valerius, R Repp, T P de Wit, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1994
Detection of soft-tissue infections and osteomyelitis using a technetium-99m-labeled anti-granulocyte monoclonal antibody fragmentW Becker, J Bair, T Behr, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1996
In vivo blockade of TNF-alpha by intravenous infusion of a chimeric monoclonal TNF-alpha antibody in patients with rheumatoid arthritis. Short term cellular and molecular effectsH M Lorenz, C Antoni, T Valerius, et al.Journal of Hematotherapy|October 1, 1995
G-CSF-stimulated PMN in immunotherapy of breast cancer with a bispecific antibody to Fc gamma RI and to HER-2/neu (MDX-210)R Repp, T Valerius, G Wieland, et al.British Journal of Haematology|December 17, 2003
Asymmetric multiplex-polymerase chain reaction - a high throughput method for detection and sequencing genomic fusion sites in t(4;11)M Metzler, U Brehm, T Langer, et al.European Journal of Medical Research|March 1, 2006
Successful autologous stem cell transplantation in a severely immunocompromised patient with relapsed AIDS-related B-cell lymphomaChristian Hoffmann, R Repp, R Schoch, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1996
Bifunctional NHS-BAT ester for antibody conjugation and stable technetium-99m labeling: conjugation chemistry, immunoreactivity and kit formulationM Eisenhut, W D Lehmann, W Becker, et al.Blood|December 1, 1994
Pre-pre-B acute lymphoblastic leukemia: high frequency of alternatively spliced ALL1-AF4 transcripts and absence of minimal residual disease during complete remissionJ W Janssen, W D Ludwig, A Borkhardt, et al.Deutsche Medizinische Wochenschrift (1946)|October 25, 2002
[Increased response rate with rituximab in relapsed and refractory follicular and mantle cell lymphomas -- results of a prospective randomized study of the German Low-Grade Lymphoma Study Group]R Forstpointner, A Hänel, R Repp, et al.Pageof 8